PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Adding radiation to hormone therapy for prostate cancer treatment will increase survival chances

2010-10-26
(Press-News.org) Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

From 1995 to 2005, 1,205 men with high-risk prostate cancer in the United States, the United Kingdom and Canada were randomly selected to receive hormone therapy alone or a combination of hormone therapy and radiation treatment and were followed for at least six years on average. The study was jointly conducted by the National Cancer Institute of Canada, the United Kingdom Medical Research Council and the Southwest Oncology Group in the United States.

Interim results of the study show that the addition of radiation therapy significantly decreased the risk of death among these patients. There were also no increased long-term side effects associated with the treatment. The independent data monitoring committee recommended the release of these results for presentation in view of their importance. The final analysis will be released after further follow-up with the patient group.

"If the figures from the interim analysis are similar to the final analysis, we would expect a 43 percent reduction in the chances of death from prostate cancer in men with this regimen," Malcolm Mason, M.D., lead author of the study and a radiation oncologist at Cardiff University in Cardiff, Wales, United Kingdom, said. "This would translate into a reduction in the chances of deaths from prostate cancer in many thousands of men worldwide."

There is much variation in the treatment for men with localized, high-risk prostate cancer and it is a hotly debated topic. While the number of men treated with combined hormone and radiation therapy has increased in recent years, there are still many patients treated with hormone therapy alone.

This multicenter, randomized trial examined the effects of external beam radiation treatment added to lifelong androgen deprivation therapy for prostate cancer patients who had a high risk of the cancer returning after treatment.

During external beam radiation therapy, radiation beams are directed through the skin to the prostate and the immediate surroundings to destroy the main tumor and any nearby cancer cells. The treatments are outpatient and generally painless, much like receiving an X-ray. Side effects most often reported are mild bowel and bladder problems. Patients typically do not experience hair loss or nausea like with some other treatments.

Androgen deprivation therapy is hormone therapy used to treat prostate cancer by lowering the level of male hormones (androgens) to shrink the prostate or slow down the growth of prostate cancer.

"This study is practice changing as it highlights the importance of radiation in the treatment of high-risk prostate cancer patients and clearly demonstrates its benefits," Dr. Mason said. "It shows that the standard treatment for these patients should now be hormone therapy plus radiation."

###

For more information on radiation therapy for prostate cancer, visit www.rtanswers.org.

The abstract, "Intergroup Randomized Phase 3 Study Of Androgen Deprivation Therapy (ADT) + Radiation Therapy (RT) In Locally Advanced Prostate Cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)," will be presented at the plenary session at 2:30 p.m. on Monday, November 1, 2010. To speak to the lead author of the study, Malcolm Mason, M.D., please call Beth Bukata or Nicole Napoli on October 31 - November 2, 2010, in the ASTRO Press Room at the San Diego Convention Center at 619-525-6313 or 619-525-6314. You may also e-mail them at bethb@astro.org or nicolen@astro.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

New American Chemical Society Prized Science video focuses on 'green gasoline'

New American Chemical Society Prized Science video focuses on green gasoline
2010-10-26
WASHINGTON, Oct. 25, 2010 — Green gasoline is plants in your tank, motor vehicle fuel made from corn, cornstalks, sugarcane, and other crops. It also is gasoline made with recipes that reduce the need for harsh, potentially toxic ingredients like hydrofluoric acid or sulfuric acid that are used at about 210 oil refineries worldwide. Now scientists have found an answer to a half-century quest for a way to make gasoline in exactly that kind of greener, more environmentally-friendly way. That advance highlights the second episode of a new video series, Prized Science: ...

Highly targeted radiation technique minimizes side effects of prostate cancer treatment

2010-10-26
Men with prostate cancer treated with a specialized type of radiation called intensity modulated radiation therapy (IMRT) have fewer gastrointestinal complications compared to patients treated with conventional three-dimensional conformal radiotherapy (3D-CRT), according to a study presented November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). "With survivors living many years after treatment, it is very important to minimize gastrointestinal and urinary side effects to allow patients to live a full life after treatment," ...

Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphoma

2010-10-26
A lower dose of radiation used to reduce side effects is not as effective as the regular dose when given with the standard chemotherapy in the treatment of Hodgkin's lymphoma patients with early, intermediate-stage disease, according to a first-of-its-kind randomized study presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). In addition, the trial showed that a more intensive chemotherapy (BEACOPP) is not more effective than the standard chemotherapy treatment (ABVD) for these patients. "This ...

What can country of birth tell us about childhood asthma?

2010-10-26
BOSTON (October 25, 2010) — Researchers from Tufts University pooled data from five previous epidemiological studies to investigate the prevalence of asthma in children in the Boston neighborhoods of Chinatown and Dorchester. Among children born in the United States, low socioeconomic status (SES) and exposure to pests (mice and cockroaches) were both associated with having asthma. Neither association was present in children born outside of the United States. The study was published online in advance of print in the Journal of Immigrant and Minority Health. "In earlier ...

Chemotherapy plus radiation prevents bladder cancer recurrences

2010-10-26
Adding chemotherapy to radiation therapy for muscle invasive bladder cancer allows 67 percent of people to be free of disease in their bladders two years after treatment. This compares to 54 percent of people who receive radiation alone, according to the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). "The trial shows that this treatment offers improved control of cancer within the bladder with acceptable long-term side effects and is therefore a ...

Radiation therapy improves painful condition associated with multiple sclerosis

2010-10-26
Stereotactic radiation is an effective, long-term treatment for trigeminal neuralgia: a painful condition that occurs with increased frequency in patients with multiple sclerosis (MS). Radiation is noninvasive and has less negative side effects than other treatments, according to the longest follow-up in a study of its kind presented October 31, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). Multiple sclerosis is a progressive neurological disease affecting about 300,000 Americans where the body's immune system attacks its own ...

Changes in energy R&D needed to combat climate change

2010-10-26
Laxenburg, Austria – 26th October 2010 -- A new assessment of future scenarios that limit the extent of global warming cautions that unless current imbalances in R&D portfolios for the development of new, efficient, and clean energy technologies are redressed, greenhouse gas (GHG) emission reduction targets are unlikely to be met, or met only at considerable costs. The study identifies energy efficiency as the single most important option for achieving significant and long-term reductions in GHG emissions, accounting for up to 50 percent of the reduction potential across ...

Robotic gripper runs on coffee ... and balloons

2010-10-26
ITHACA, N.Y. – The human hand is an amazing machine that can pick up, move and place objects easily, but for a robot, this "gripping" mechanism is a vexing challenge. Opting for simple elegance, researchers from Cornell University, University of Chicago and iRobot have bypassed traditional designs based around the human hand and fingers, and created a versatile gripper using everyday ground coffee and a latex party balloon. They call it a universal gripper, as it conforms to the object it's grabbing rather than being designed for particular objects, said Hod Lipson, ...

Plagiarism sleuths tackle full-text biomedical articles

2010-10-26
In scientific publishing, how much reuse of text is too much? Researchers at the Virginia Bioinformatics Institute at Virginia Tech and collaborators have shown that a computer-based text-searching tool is capable of unearthing questionable publication practices from thousands of full-text papers in the biomedical literature. The first step in the process is to find out what is restated before zeroing in on who may have crossed an ethically unacceptable threshold. The findings, published in PLoS ONE, offer hope for curbing unethical scientific publication practice, ...

Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies

Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
2010-10-26
VIDEO: This video contains more on the pediatric bone cancer preclinical study. Click here for more information. BOSTON - Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer. In their study, researchers at The University of Texas MD Anderson Children's Cancer Hospital in Houston found that blocking the Notch pathway in mice decreased metastases in the lungs 15-fold. The results of ...

LAST 30 PRESS RELEASES:

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

Compound metalens achieves distortion-free imaging with wide field of view

Age on the molecular level: showing changes through proteins

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

[Press-News.org] Adding radiation to hormone therapy for prostate cancer treatment will increase survival chances